Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) — Stock Score Summary

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) has a MoatMap StockRank of 85/100 based on Quality (74/100), Value (51/100), and Momentum (45/100) factor scores. The current signal is STRONG BUY. Tonghua Dongbao is a Chinese insulin manufacturer. While it has high quality metrics (Q: 74), it does not operate as a CDMO and is highly exposed to China's volume-based procurement (VBP) price cuts, destroying its pricing power.

Tonghua Dongbao Pharmaceutical is a leading Chinese biopharmaceutical company specializing in the R&D, production, and sale of insulin and other diabetes treatment products. The company holds a dominant market position in China's domestic recombinant human insulin market, supported by its large-scale manufacturing capabilities and extensive distribution network. It is recognized as a pioneer in China's domestic insulin industry, reducing reliance on imported biological drugs.

Key Financial Metrics

Price$1.10
Market Cap$2.4B
P/E (TTM)12.76
P/E (Forward)21.97
Price/Book2.14
Return on Equity17.6%
Return on Invested Capital20.4%
Debt/Equity9.44
Gross Margin70.5%
Operating Margin21.2%
Revenue Growth14.8%
Dividend Yield3.6%
Free Cash Flow$8M

Tonghua Dongbao Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Tonghua Dongbao Pharmaceutical Co., Ltd.’s (600867.SS) StockRank?
MoatMap’s StockRank for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is 85/100, with a Strong Buy signal. It is a composite of Quality (74), Value (51), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tonghua Dongbao Pharmaceutical Co., Ltd. have an economic moat?
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) has a Quality factor score of 74/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tonghua Dongbao Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is Strong Buy, based on a StockRank of 85/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tonghua Dongbao Pharmaceutical Co., Ltd. in?
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks600867.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock